EUVIMEDEUVIMED entdecken
Crossref

The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived

Paul M Ridker iD

Circulation · 2023

DOI: 10.1161/circulationaha.123.066510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, 2023. Verfasst von Paul M Ridker. Beteiligte Einrichtung: Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women's Hospit…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Atherosclerosis. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseAtherosclerosisHumansAnti-Inflammatory AgentsInflammation

Stichwörter der Autor:innen

atherosclerosisinflammationpreventiontreatment

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA.

ORCID-Profile: Paul M Ridker

Zitieren

APA

Ridker, P. M. (2023). The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived. Circulation. https://doi.org/10.1161/circulationaha.123.066510

Vancouver

Ridker PM. The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived. Circulation. 2023. doi:10.1161/circulationaha.123.066510

BibTeX
@article{Ridker2023,
  author = {Ridker, Paul M},
  title = {The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived},
  journal = {Circulation},
  year = {2023},
  doi = {10.1161/circulationaha.123.066510}
}
Kostenlos starten →